AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Goodkind Labaton Rudoff & Sucharow LLP files class action lawsuit against Purdue Pharma LP.

Asia Africa Intelligence Wire

| February 10, 2004 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Press Release)

Goodkind Labaton Rudoff & Sucharow LLP filed an antitrust class action in the US District Court for the Southern District of New York on behalf of Union Welfare Funds, challenging alleged deceptive and monopolistic acts of Purdue Pharma and Purdue Pharma LP, The Purdue Frederick Co, The PF Laboratories Inc, The Purdue Pharma Co, Abbott Laboratories, and Euroceltique SA in sales of OxyContin (controlled-release oxycodone hydrochloride prescription tablets). The complaint alleges that Purdue Pharma obtained exclusive selling rights of oxycodone hydrochlorine by virtue of inequitable conduct, including misrepresentations …

Related articles from newspapers, magazines, journals, and more
Purdue Pharma LP announces signing of consent judgement ending OxyContin...
News wire article from: Chemical Business Newsbase October 16, 2006 700+ words
Purdue Pharma LP announces resolution of OxyContin patent lawsuit with Endo...
News wire article from: Chemical Business Newsbase August 28, 2006 700+ words
Purdue Pharma LP and Shionogi sign multi-year research and worldwide...
News wire article from: Chemical Business Newsbase January 10, 2006 700+ words
Purdue Pharma LP Launches Pharmacy Safety and Security Video
News wire article from: Europe Intelligence Wire November 13, 2012 700+ words
Purdue Pharma LP announces agreement to end OxyContin patent lawsuit with...
News wire article from: Chemical Business Newsbase August 29, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily